Skip to main content
. 2015 Jun 1;2015(6):CD009566. doi: 10.1002/14651858.CD009566.pub2

Dharmistha 2013.

Methods No details, unclear if it is a RCT
Participants Allergic conjunctivitis
Interventions Topical olopatadine hydrochloride 0.1% versus ketotifen fumarate 0.025%
Outcomes Unclear
Notes None